[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-468527-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-468527-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","proteomic-analysis-of-nulisa-plasma-analytes-associations-with-neurocognitive-measures-and-incident-dementia-in-older-adults","Proteomic Analysis of NULISA™ plasma analytes - Associations with Neurocognitive measures and Incident Dementia in older adults","","Neurodegenerative diseases show progressive cognitive decline, and plasma biomarkers may support early detection and risk assessment for Alzheimer’s disease. Using the Nucleic Acid–Linked Immuno-Sandwich Assay (NULISA™), the study quantified low-abundance proteins linked to Alzheimer’s pathology. Associations between NULISA™ plasma biomarkers and cognitive performance were tested, and predictive value for incident dementia in older adults was evaluated.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/proteomic-analysis-of-nulisa-plasma-analytes-associations-with-neurocognitive-measures-and-incident-dementia-in-older-adults/468527/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/proteomic-analysis-of-nulisa-plasma-analytes-associations-with-neurocognitive-measures-and-incident-dementia-in-older-adults/468527.png","ImageObject",300,407,{"name":42,"@type":43},"Kyle","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-06","2026-09-30",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the study’s primary goal?","Question",{"text":63,"@type":64},"To evaluate how NULISA™-quantified plasma biomarkers relate to neurocognitive performance and whether they predict incident dementia in older adults.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which assay platform and biomarker categories were used?",{"text":68,"@type":64},"Plasma biomarkers were measured with the NULISA™ CNS 126 protein platform, including ATN and I biomarkers: Aβ42/Aβ40 (and their ratio), p-tau isoforms (and ratios), NfL/total tau, and GFAP.",{"name":70,"@type":61,"acceptedAnswer":71},"What main finding was reported about incident dementia?",{"text":72,"@type":64},"Among the analyzed NULISA proteins, Growth differentiation factor 15 was the only protein associated with incident dementia in the ARIC sample.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},468527,1792789481,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":26,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":97,"preview_page_count":26,"preview_urls":144},3985741905716,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","DOI: 10. 1002/alz70856_107037  \nBIOMARKERS  \nPOSTER PRESENTATION  \nBIOMARKERS (NON-NEUROIMAGING)  \nProteomic Analysis of NULISA™ plasma analytes and Associations with Neurocognitive measures and Incident Dementia in older adults  \nJoshua L Gills1  Hubert Leo2  Omonigho M Bubu 1  TheARIC Neurocognitive  \nBiomarker Workgroup  \n1 NYU Grossman School of Medicine, New York, NY, USA  \n2 New York University Langone Health, New York City, NY, USA  \nCorrespondence  \nJoshua L Gills, NYU Grossman School of Medicine, New York, NY, USA. [Email:](Email: joshua.gills@nyulangone.org)[ joshua.gills@nyulangone.org](Email: joshua.gills@nyulangone.org)  \nAbstract  \nBackground: Neurodegenerative diseases, including Alzheimer’s disease (AD), are characterized by progressive cognitive decline, with plasma biomarkers potentially playing a key role in early detection and risk assessment. The Nucleic Acid– Linked Immuno-Sandwich Assay (NULISA™) offers high sensitivity for measuring low-abundance proteins associated with AD pathology, including Aβ42/Aβ40, p-tau isoforms, NfL, and GFAP. We examined the associations between NULISA™-quantified plasma biomarkers and cognitive performance and investigated their predictive value for incident dementia in older adults.  \nMethod: This study utilized data from 116 ARIC cohort participants with available plasma samples. Plasma biomarkers were quantified using the NULISA™ CNS 126 protein platform. ATN & I biomarkers included: A (Aβ proteinopathy)– Aβ-42, Aβ - 40, and Aβ-42/40; T (phosphorylated and secreted AD tau) - p-tau217, p-tau181, p-tau231 and their ratios with Aβ-42; N (neuropil injury)– NfL and Total Tau; and I (inflammation)– GFAP. Cognitive performance was assessed using global and domainspecific neurocognitive tests, and incident dementia cases were identified through longitudinal follow-up. Linear regression and Cox proportional hazards models were used to examine biomarker associations with baseline cognition and dementia risk, adjusting for age, sex, APOE ε4 status, education, and glomerular filtration rate. FWE correction was utilized for multiple comparison adjustments.  \nResult: The 116 participants were on average 74.3 ± 4. 7 years old, 88.8% were cognitively normal, 29.7% were APOE4 carriers, and overweight (BMI=29.7±5.5 kg/mˆ 2). Of the NULISA Alamar 126 proteins, Growth differentiation factor 15 was the only protein associated with Incident Dementia (β = 4.7, p \u003C 0.001). Antigen CD63 (β = -0.43, p \u003C 0.001) and Eotaxin CCL11 (β = -0.37, p \u003C 0.001) were associated  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \n© 2025 The Alzheimer’s Association. Alzheimer’s & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer’s Association.  \nAlzheimer’s Dement. 2025;21(Suppl. 2):e107037.  \n[https://doi.org/10.1002/alz70856_107037](https://doi.org/10.1002/alz70856_107037)  \nwi[leyonlinelibrary.com/journal/alz](leyonlinelibrary.com/journal/alz)  \n1of2  \nBIOMARKERS  \nwith global cognition. Growth Regulated Alpha Protein CXCL1 was associated with executive function (β = -0.33, p \u003C 0.001). No significant relationships were identified between NULISA Alamar 126 proteins and language or memory scores.  \nConclusion: Proteins subserving functions related to synaptic vesicle exocytosis and inflammation were associated with cognition and incident dementia in the ARIC sample, but power is limited to evaluate the full range of proteins. Future investigations should increase the sample size to identify other novel proteomic pathways related to cognition and incident dementia.","cbCaica3PFdJsEUL","https://ap.wps.com/l/cbCaica3PFdJsEUL","pdf",97433,"English","# Abstract\n## Background\n## Method\n## Result\n## Conclusion","[{\"question\":\"What is the study’s primary goal?\",\"answer\":\"To evaluate how NULISA™-quantified plasma biomarkers relate to neurocognitive performance and whether they predict incident dementia in older adults.\"},{\"question\":\"Which assay platform and biomarker categories were used?\",\"answer\":\"Plasma biomarkers were measured with the NULISA™ CNS 126 protein platform, including ATN and I biomarkers: Aβ42/Aβ40 (and their ratio), p-tau isoforms (and ratios), NfL/total tau, and GFAP.\"},{\"question\":\"What main finding was reported about incident dementia?\",\"answer\":\"Among the analyzed NULISA proteins, Growth differentiation factor 15 was the only protein associated with incident dementia in the ARIC sample.\"}]","Proteomic Analysis of NULISA™ plasma analytes - Associations with Neurocognitive measures and Incident Dementia in older adults | PDF",1790774353,[145,149],{"page_no":22,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/b5c6d1b6a1cf2f86b51b81d49c759fe5.webp",983,1291,{"page_no":26,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/1b1f3e9b405a4e68e286ecc4347f9afe.webp",982,1290]